Evotec SE (EVO) Non-Current Assets (2009 - 2026)

Evotec SE (EVO) reported Non-Current Assets of $1.1 million for Q1 2026, down 15.36% on a YoY basis from $1.3 million in Q1 2025, and down 1.8% sequentially from $1.1 million in Q4 2025.

Evotec SE (EVO) Non-Current Assets (2009 - 2026) Analysis & Trends

Evotec SE (EVO) has 9 years of Non-Current Assets data on file, last reported at $1.1 million in Q1 2026.

  • For the quarter ending Q1 2026, Non-Current Assets fell 15.36% year-over-year to $1.1 million; the trailing twelve-month figure through Mar 2026 stood at $1.1 million (down 15.36% YoY), and the FY2025 full-year result was $1.1 million, down 99.91% from the prior year.
  • Non-Current Assets retreated to $1.1 million in Q1 2026, from $1.1 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $1.3 billion in Q4 2023 to a low of $1.1 million in Q1 2026.
  • A 5-year average of $302.6 million and a median of $1.3 million in 2025 frame the typical range for Non-Current Assets.
  • Across the five-year window, Non-Current Assets advanced 21.02% in 2023 and plunged 99.91% in 2025, its largest moves.
  • Tracing EVO's Non-Current Assets over 5 years: stood at $1.1 billion in 2022, then gained by 21.02% to $1.3 billion in 2023, then decreased by 1.37% to $1.3 billion in 2024, then slumped by 99.91% to $1.1 million in 2025, then declined by 1.8% to $1.1 million in 2026.
  • Business Quant data shows EVO's Non-Current Assets at $1.1 million in Q1 2026, $1.1 million in Q4 2025, and $1.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 36.78 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 26.33 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 8.68 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 79.20 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 3.84 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 15.70 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 25.92 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 2.47 Bn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 9.64 Bn
10 Evotec SE 351.60 Mn 351.08 Mn - 1.09 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.09 Mn
Dec 31, 2025 1.11 Mn
Sep 30, 2025 1.15 Mn
Jun 30, 2025 1.36 Mn
Mar 31, 2025 1.28 Mn
Dec 31, 2024 1.27 Bn
Sep 30, 2024 1.42 Mn
Mar 31, 2024 1.50 Mn
Dec 31, 2023 1.29 Bn
Dec 31, 2022 1.06 Bn
Sep 30, 2022 1.18 Mn
Mar 31, 2022 1.26 Mn
Dec 31, 2021 970.17 Mn
Sep 30, 2021 1.34 Mn
Dec 31, 2020 898.44 Mn
Sep 30, 2010 125,722.18
Jun 30, 2010 90,917.59
Mar 31, 2010 108.58
Dec 31, 2009 114,656.60
Jun 30, 2009 114.84 Mn